Wednesday, November 30, 2016

21st Century Cures Act reboot keeps controversial changes for FDA
With the fast-tracked reboot of the 21st Century Cures Act, drug and device manufacturers may be about to win long sought revisions to the way the Food and Drug Administration approves and regulates their products.  READ MORE
Cures Act would give pass to lowest-quality Medicare Advantage plans 
If Congress passes the 21st Century Cures Act, the federal government would be barred from axing the worst performers in Medicare Advantage through 2018.  READ MORE
Trump's CMS pick is viewed as both patient advocate and foe
Verma has supported charging premiums to individuals above and below the poverty line and freezing beneficiaries out of coverage if they don't pay. But she could prove to be a knowledgeable ally to states looking to better control their Medicaid dollars.  READ MORE